Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. - Wikidata - awgldk - TriplyDB

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

http://www.wikidata.org/entity/Q42519640

about

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers Understanding and treating triple-negative breast cancer Risk factors for triple-negative breast cancer in women under the age of 45 years Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting Targeting triple-negative breast cancer: optimising therapeutic outcomes Innate and adaptive immune cells in the tumor microenvironment The STING pathway and the T cell-inflamed tumor microenvironment Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors Molecular Classification of Triple-Negative Breast Cancer Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis Unraveling the microenvironmental influences on the normal mammary gland and breast cancer Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.A systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy.Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium.Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base.An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer.Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability Knowledge driven decomposition of tumor expression profiles Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.Role of postmastectomy radiotherapy in early-stage (T1-2N0-1M0) triple-negative breast cancer: a systematic review.An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays.Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models FBP1 expression is associated with basal-like breast carcinoma Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.

P2860

Q21134780-957B6705-E571-4BCA-B04A-DE0788793CCE Q21261291-A90BE8B1-9A76-44A2-BF1C-A03E45BC5AB7 Q24313363-44ACD551-0844-448A-AB13-6D610ABB5F81 Q24620397-6582BC28-A97C-4C80-B682-32D2BC0364B4 Q24620957-CD90DB1A-E4D1-4049-9012-2E3CFF15119A Q24644075-A7FFAB62-882C-4F96-BFE6-0D594BCF3D4E Q26747792-AB33510D-5113-406D-96C1-E548932287D6 Q26850892-469D001C-732D-43B7-AE86-71D1605C88F7 Q27008342-DFE59C28-B526-4464-926B-C3B02BF9F366 Q27008371-00CEE472-7913-433D-B12D-B588A79B0DF0 Q27437626-A5CEA840-56B6-4B92-81CF-7BE1413ABFB9 Q28076661-1FCC428B-C880-4082-90B1-3FA5132696E3 Q28259744-5C7D98AE-04ED-48DD-984A-1890F1432579 Q28372484-66C4B830-0FED-4C5F-9972-FCF6A3DA8751 Q28388257-7AADFC79-FA38-4148-8BEA-37E840890321 Q28473677-F86B2323-2E26-4C6A-AC67-7DF15439EF77 Q29617680-2E1DD491-62AF-429E-A6F0-3DF0BC281A82 Q30245184-CC6632CB-4DC8-41CF-B34C-F49C4B5A1513 Q30423830-9F1765EC-07A3-4A74-9E13-CCC846DB8F0B Q30437453-7DEA068D-826F-48F6-9E55-E1F1720710B2 Q30477571-CF33E6FB-EA81-495B-B413-808AB8B22D80 Q30525532-73E5B0F5-CD2A-4CB3-9E64-282FA62E80A0 Q30596512-7F1F9AE6-6DD1-4602-BB17-7AC4F0EF6C90 Q33355327-4FF0144F-4D11-4C06-8BD0-501672213C11 Q33358309-52BBA6B6-CA5C-48A4-BFC2-87938C26E509 Q33407774-D84280FE-BBB0-4551-82EE-9158F5483EFC Q33416006-14978F8D-89DD-4F65-96BD-03F71587F502 Q33500786-9C1500BF-6658-4C9A-B4BF-722B701611F2 Q33552870-27AE1DD3-78B4-4EA1-9152-31A16644FE1A Q33553668-188CF37C-C169-46C1-8F3A-4ACAF1397D75 Q33579640-B1C7E0AA-FCF0-4233-B19C-3AF29ACBF9F9 Q33607569-19020C43-3CD6-4494-826A-4374B0E2DB11 Q33660965-816E1F06-91E7-471A-BF13-7C48EF021539 Q33686009-A9914DEF-0070-47F5-8C48-0F5EE1C0052A Q33699438-6C3B433F-5596-4CE8-8F13-EF54FB88619E Q33738285-05712EAC-E8F4-4B34-8B4B-6171508FCA08 Q33739387-53D043C8-4E59-4F38-99F9-B8B194CD9686 Q33757116-C1C6CF69-7EF6-4968-B123-77F390C9632A Q33762138-39D5AA89-3F16-44B2-858A-46156E9680A6 Q33780945-F4F403EF-410C-4253-9B36-7CB55C8E75AD

P2860

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

http://www.wikidata.org/entity/Q42519640

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Gene expression profiling and ...... /basal-like breast carcinomas.

@en

Gene expression profiling and ...... /basal-like breast carcinomas.

@nl

type

label

Gene expression profiling and ...... /basal-like breast carcinomas.

@en

Gene expression profiling and ...... /basal-like breast carcinomas.

@nl

prefLabel

Gene expression profiling and ...... /basal-like breast carcinomas.

@en

Gene expression profiling and ...... /basal-like breast carcinomas.

@nl

P1433

Q42519640-41662D92-900A-4267-8EB2-00FB69560A57

P1476

Q42519640-23E807BF-99AC-4F19-8CFB-5372658C8A1E

P2093

Q42519640-06E4AF56-3505-4C4A-AC33-75101498AA35

Q42519640-15358DF1-2DA4-4B41-BBCD-1FE4AC0AA63A

Q42519640-3B317DAF-0ACE-45CE-B0E0-86CF9A3784F1

Q42519640-AC2784E6-AC45-4629-9A29-A6B8397EF0C8

Q42519640-B0776233-F2B9-4269-8092-BFCA71E4BEB1

P2860

Q42519640-0310C151-68EB-4860-97B4-4250C8A5A8CD

Q42519640-086872A2-6BA8-49C5-AD42-2FB01BCB911F

Q42519640-0D61AF6C-34D2-4ACE-88EB-BCF36169BF8B

Q42519640-15E8E594-4897-44D1-A856-2F1360343574

Q42519640-185D3898-E5E5-4692-9FBD-A6AD1A784E6E

Q42519640-203532D6-16BD-4872-AE89-5AE1A4CD2707

Q42519640-21FD9805-F4B9-4CD0-8DC8-6E2F2FCBD7B0

Q42519640-29B0ABE4-7400-4D72-A9EE-90642C8D48F1

Q42519640-3B702EA9-4C11-46AE-97F9-38C057574AC3

Q42519640-3DF29825-78EF-452A-B141-8FC4EFD6D1A4

P2888

Q42519640-F833243C-4F72-48D3-AF34-EEE8B15EA2C8

P304

Q42519640-1901C825-5DE7-4CF5-A067-791ACC652FBD

P31

Q42519640-B73FBA1C-2208-41B7-8C04-2A487D0ED7E9

P356

Q42519640-1FDF020F-BC20-4F0C-B162-8C9E57EFE902

P433

Q42519640-87C62716-90C3-4621-AD68-32F777B19988

P478

Q42519640-78F092EA-DC14-4D5C-B76F-8606E5B744ED

P50

Q42519640-6FC9CF48-D057-4DF8-9A02-DEA8AB7A595B

Q42519640-C1F918D8-D016-411C-A367-0D1D16B016EC

P577

Q42519640-D6F90F30-5160-4EB2-B296-B8B4342B5B41

P5875

Q42519640-B77D6E3F-77FB-4C97-BEEB-6866C3085B4E

P6179

Q42519640-B3FA506B-521A-4427-8CD2-DE8F5F531248

P698

Q42519640-116B0FE0-8233-454B-B691-291C7415CD78

P932

Q42519640-8116332E-3457-4469-9103-663EB32AF566

P356

P1433

Breast Cancer Research

P1476

Gene expression profiling and ...... /basal-like breast carcinomas.

@en

P2093

Bas Kreike

http://www.w3.org/2001/XMLSchema#string

Hans Peterse

http://www.w3.org/2001/XMLSchema#string

Harry Bartelink

http://www.w3.org/2001/XMLSchema#string

Hugo Horlings

http://www.w3.org/2001/XMLSchema#string

Marieke van Kouwenhove

http://www.w3.org/2001/XMLSchema#string

P2860

Significance analysis of microarrays applied to the ionizing radiation response

Identifying biological themes within lists of genes with EASE

Cluster analysis and display of genome-wide expression patterns

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Functional discovery via a compendium of expression profiles.

Molecular portraits of human breast tumours

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

P2888

P304

R65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1771

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Marc van de Vijver

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5933818

http://www.w3.org/2001/XMLSchema#string

P6179

1006375768

http://www.w3.org/2001/XMLSchema#string

P698

17910759

http://www.w3.org/2001/XMLSchema#string

P932

2242660

http://www.w3.org/2001/XMLSchema#string